Find Loteprednol Etabonate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 82034-46-6, Lotemax, Alrex, Hgp-1, Inveltys, Cddd-5604
Molecular Formula
C24H31ClO7
Molecular Weight
466.9  g/mol
InChI Key
DMKSVUSAATWOCU-HROMYWEYSA-N
FDA UNII
YEH1EZ96K6

Loteprednol Etabonate
An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.
1 2D Structure

Loteprednol Etabonate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
2.1.2 InChI
InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1
2.1.3 InChI Key
DMKSVUSAATWOCU-HROMYWEYSA-N
2.1.4 Canonical SMILES
CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
2.1.5 Isomeric SMILES
CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl
2.2 Other Identifiers
2.2.1 UNII
YEH1EZ96K6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl

2. Alrex

3. Cehoac

4. Chloromethyl 17 Ethoxycarbonyloxy 11 Hydroxy 3 Oxoandrosta 1,4 Diene 17 Carboxylate

5. Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate

6. Etabonate, Loteprednol

7. Lotemax

8. Loteprednol

2.3.2 Depositor-Supplied Synonyms

1. 82034-46-6

2. Lotemax

3. Alrex

4. Hgp-1

5. Inveltys

6. Cddd-5604

7. P-5604

8. Cddd 5604

9. Chloromethyl (8s,9s,10r,11s,13s,14s,17r)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-17-carboxylate

10. Chebi:31784

11. Yeh1ez96k6

12. Kpi-121

13. Dsstox_cid_26468

14. Dsstox_rid_81641

15. Dsstox_gsid_46468

16. (11b,17a)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic Acid Chloromethyl Ester

17. Chloromethyl 17alpha-[(ethoxycarbonyl)oxy]-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate

18. Loterox

19. Locort

20. Lotemax (tn)

21. Cas-82034-46-6

22. Unii-yeh1ez96k6

23. Hgp 1

24. Loteprednol Etabonate [usan]

25. Airex

26. Loteprednol Etabonate (jan/usan)

27. Loteprednoletabonate

28. Ncgc00164594-01

29. Idr-90102

30. Idr-90103

31. Eysuvis

32. Loteprednol Etabonate Opphthalmic Suspension

33. P 5604

34. Schembl23907

35. Mls001424221

36. Gtpl7085

37. Chembl1200865

38. Dtxsid2046468

39. Hms2051f16

40. Hms2232j09

41. Hms3715n06

42. Loteprednol Etabonate [mi]

43. Loteprednol Etabonate [usan:jan]

44. Loteprednol Etabonate [jan]

45. Bcp28645

46. Zinc3920673

47. Tox21_112219

48. Bdbm50248301

49. Loteprednol Etabonate [vandf]

50. Mfcd00870765

51. S1669

52. Loteprednol Etabonate [mart.]

53. Akos005145741

54. Loteprednol Etabonate [who-dd]

55. Tox21_112219_1

56. Ccg-101041

57. Cs-0900

58. Db14596

59. Gs-3599

60. Nc00291

61. Loteprednol Etabonate, >=98% (hplc)

62. Ncgc00164594-02

63. Chloromethyl 11beta,17-dihydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate, 17-(ethyl Carbonate)

64. Hy-17358

65. Smr000469178

66. Loteprednol Etabonate [orange Book]

67. Zylet Component Loteprednol Etabonate

68. L0327

69. D01689

70. Loteprednol Etabonate Component Of Zylet

71. Ab00698349-05

72. Ab00698349-07

73. Ab00698349_08

74. 034l466

75. Q3837481

76. Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, Chloromethyl Ester, (11.beta.,17.alpha.)-

77. Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, Chloromethyl Ester, (11beta,17alpha)-

78. Chloromethyl (1s,2r,10s,11s,14r,15s,17s)-14-[(ethoxycarbonyl)oxy]-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carboxylate

79. Chloromethyl 11.beta.,17-dihydroxy-3-oxoandrosta-1,4-diene-17.beta.-carboxylate, 17-(ethyl Carbonate)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 466.9 g/mol
Molecular Formula C24H31ClO7
XLogP33.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass466.1758310 g/mol
Monoisotopic Mass466.1758310 g/mol
Topological Polar Surface Area99.1 Ų
Heavy Atom Count32
Formal Charge0
Complexity882
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameAlrex
Drug LabelALREX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use.Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following structura...
Active IngredientLoteprednol etabonate
Dosage FormSuspension/drops
RouteOphthalmic
Strength0.2%
Market StatusPrescription
CompanyBausch And Lomb

2 of 4  
Drug NameLotemax
PubMed HealthLoteprednol (Into the eye)
Drug ClassesOphthalmologic Agent
Drug LabelLOTEMAX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use. Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following struct...
Active IngredientLoteprednol etabonate
Dosage FormOintment; Gel; Suspension/drops
RouteOphthalmic
Strength0.5%
Market StatusPrescription
CompanyBausch And Lomb

3 of 4  
Drug NameAlrex
Drug LabelALREX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use.Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following structura...
Active IngredientLoteprednol etabonate
Dosage FormSuspension/drops
RouteOphthalmic
Strength0.2%
Market StatusPrescription
CompanyBausch And Lomb

4 of 4  
Drug NameLotemax
PubMed HealthLoteprednol (Into the eye)
Drug ClassesOphthalmologic Agent
Drug LabelLOTEMAX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use. Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following struct...
Active IngredientLoteprednol etabonate
Dosage FormOintment; Gel; Suspension/drops
RouteOphthalmic
Strength0.5%
Market StatusPrescription
CompanyBausch And Lomb

4.2 Drug Indication

A number of prescription loteprednol etabonate ophthalmic products are specifically indicated for the treatment of post-operative inflammation and pain following ocular surgery.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Loteprednol etabonate (LE) belongs to a unique class of corticosteroids with potent anti-inflammatory effects designed to be active at the site of action. Animal studies have shown that LE has a binding affinity to steroid receptors that is 4.3 times greater than dexamethasone. This particular class of steroids consists of bioactive molecules whose in-vivo transformation to non-toxic substances can be predicted from their chemistry and knowledge of enzymatic pathways in the body. Cortienic acid is an inactive metabolite of hydrocortisone and analogs of cortienic acid are also devoid of corticosteroid activity. Specifically, LE is an ester derivative of one of these analogs, cortienic acid etabonate. In particular, LE possesses a metabolically labile 17 beta-chloromethyl ester function which was designed in order to be hydrolyzed to an inactive carboxylic acid moiety. This inactive metabolite is more hydrophilic and is thus readily eliminated from the body. LE also exhibits good ocular permeation properties and good skin permeation properties.


5.2 MeSH Pharmacological Classification

Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Pharmacological Classes
Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]
5.4 Absorption, Distribution and Excretion

Absorption

Loteprednol etabonate (LE) demonstrates good ocular permeation properties as it is lipid soluble, allowing the agent to penetrate into cells with relative ease. Results from the ocular administration of loteprednol in normal, healthy volunteers have shown that there are low or undetectable concentrations of either unchanged material or its metabolite. Following twice-daily unilateral topical ocular dosing of LE for 14 days in healthy subjects, the plasma concentrations of loteprednol etabonate were below the limit of quantitation (1 ng/mL) at all time points. These finds suggest that limited, if any, systemic absorption of LE occurs.


Route of Elimination

Following systemic administration to rats, loteprednol etabonate is eliminated primarily via the biliary/faecal route, with most of the dose eliminated in the form of the metabolite, PJ-90.


Volume of Distribution

The only data available regarding the volume of distribution of loteprednol etabonate (LE) is the volume of distribution the agent demonstrated when administered to dogs - a value of 3.7 L/kg. It has been shown, however, that the topical ocular administration of LE distributes preferentially into the cellular components of blood.


Clearance

Loteprednol etabonate was slowly hydrolyzed in liver at clearance rates of 0.21 +/- 0.04 and 2.41 +/- 0.13 ml/h/kg in the liver and plasma, respectively.


5.5 Metabolism/Metabolites

Loteprednol etabonate (LE) is readily and extensively metabolized to two inactive metabolites, PJ-90 (1-cortienic acid) and PJ-91 (1-cortienic acid etabonate). Metabolism occurs locally in ocular tissues, and to the extent that loteprednol etabonate reaches the systemic circulation, likely the liver and other tissues into which it distributes. In particular, studies have demonstrated that LE (chloromethyl 17alpha-ethoxycarbonyloxy-11beta-hydroxy-3-oxoandrosta-1,4-diene) is rapidly hydrolyzed at the location of its 17beta-chloromethyl ester function by paraoxonase 1 in human plasma at the site of administration at the level of the affected eye tissue to the 17beta-carboxylate PJ-91 metabolite and PJ-90 metabolite. Both metabolites are considered inactive.


5.6 Biological Half-Life

The terminal half-life of loteprednol etabonate as determined when administered intravenously at a dose of 5 mg/kg in the dog animal model is 2.8 hours.


5.7 Mechanism of Action

Corticosteroids like loteprednol etabonate inhibit the inflammatory response to a variety of inciting agents and likely delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation that are commonly associated with inflammation. While glucocorticoids are known to bind to and activate the glucocorticoid receptor, the molecular mechanisms involved in glucocorticoid/glucocorticoid receptor-dependent modulation of inflammation are not clearly established. Moreover, corticosteroids are thought to inhibit prostaglandin production through several independent mechanisms. In particular, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. The use of LE subsequently treats post-operative inflammation and pain following ocular surgery by managing the prostaglandin release, recruitment and travel of neutrophils and macrophages, and production of other inflammatory mediators that are intrinsically associated with the physical trauma of surgery.


USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2024-10-16

Pay. Date : 2024-10-08

DMF Number : 11105

Submission : 1994-09-26

Status : Active

Type : II

Zach System VB Company banner

02

Farmabios Spa

Germany
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2023-07-05

Pay. Date : 2023-01-24

DMF Number : 27717

Submission : 2013-11-11

Status : Active

Type : II

Axplora CB

03

Farmabios Spa

Germany
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 26937

Submission : 2013-03-05

Status : Active

Type : II

Axplora CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 26249

Submission : 2012-07-26

Status : Active

Type : II

Aarti Industries Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2014-05-29

Pay. Date : 2014-03-20

DMF Number : 28031

Submission : 2014-03-07

Status : Active

Type : II

Company Banner

06

Vietnam Medi-Pharm Expo
Not Confirmed

06

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22278

Submission : 2008-12-02

Status : Inactive

Type : II

blank

07

Chemo Iberica Sa

Spain

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

07

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2024-12-05

Pay. Date : 2024-10-25

DMF Number : 38817

Submission : 2024-03-20

Status : Active

Type : II

blank

08

Fine Organics Ltd

United Kingdom

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

08

Fine Organics Ltd

United Kingdom
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 11264

Submission : 1994-12-16

Status : Inactive

Type : II

blank

09

Vietnam Medi-Pharm Expo
Not Confirmed

09

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-12-23

Pay. Date : 2015-04-03

DMF Number : 23672

Submission : 2010-04-01

Status : Active

Type : II

blank

10

Vietnam Medi-Pharm Expo
Not Confirmed

10

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 25435

Submission : 2011-12-06

Status : Inactive

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Flag India
Digital Content Digital Content

Loteprednol Etabonate IH

Date of Issue : 2025-08-22

Valid Till : 2028-08-21

Written Confirmation Number : WC-0099

Address of the Firm : Plot No.E-50, 50/1 and 59/1, Unit-IV, MIDC, Tarapur-401506, Taluka: Palghar, Dis...

Aarti Industries Company Banner

02

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Loteprednol Etabonate IH

Date of Issue : 2025-10-24

Valid Till : 2027-10-23

Written Confirmation Number : WC-0625

Address of the Firm : PLOT NO.: В-29/1, MIDC MAHAD, VILLAGE BIRWADI,MAHAD - 402301, Taluka: MAHAD, Di...

blank

03

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Loteprednol Etabonate IH

Date of Issue : 2024-11-05

Valid Till : 2027-11-04

Written Confirmation Number : WC-0485

Address of the Firm : Block No. 203, Vaso-Alindra Road, PO Alindra-387510, Tal-Matar Dist. Kheda, Guja...

blank

04

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Loteprednol Etabonate IH

Date of Issue : 2022-08-08

Valid Till : 2025-07-14

Written Confirmation Number : WC-0168

Address of the Firm : Plot No. 24/2, & 25, Phase -IV, GIDC Industrial Zone, At & Post - Panoli, Dist.-...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.

Flag France
Digital Content Digital Content

Roteprednol etaboate

Registrant Name : Bausch Health Korea Co., Ltd.

Registration Date : 2008-05-07

Registration Number : 4063-1-ND

Manufacturer Name : Zach system

Manufacturer Address : Zone Industrielle La Croix Cadeau Avrille, 49240, France

Zach System VB Company banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Flag India
Digital Content Digital Content

Roteprednol etabonate

Registrant Name : Ace Biopharm Co., Ltd.

Registration Date : 2024-03-14

Registration Number : Su289-18-ND

Manufacturer Name : Aarti Pharmalabs Limited

Manufacturer Address : Plot No. E–50, 50/1 & 59/1, Unit-IV, MIDC, Tarapur, Taluka & District-Palghar, 401 ...

Aarti Industries Company Banner

03

HL Genomics

South Korea
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

HL Genomics

South Korea
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Roteprednol etaboate

Registrant Name : HL Genomics Co., Ltd.

Registration Date : 2016-04-04

Registration Number : 94-3-ND

Manufacturer Name : HL Genomics Co., Ltd. @ [Sta...

Manufacturer Address : 1552, Bogaewonsam-ro, Wonsam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do @ [Starting Mat...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.

Flag France
Digital Content Digital Content

LOTEPREDNOL ETABONATE

NDC Package Code : 60269-287

Start Marketing Date : 1998-03-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Zach System VB Company banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

LOTEPREDNOL ETABONATE

NDC Package Code : 46439-8744

Start Marketing Date : 2012-04-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Axplora CB

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

LOTEPREDNOL ETABONATE

NDC Package Code : 46439-8743

Start Marketing Date : 2012-04-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Axplora CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Flag India
Digital Content Digital Content

LOTEPREDNOL ETABONATE

NDC Package Code : 15308-0722

Start Marketing Date : 2011-06-30

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Aarti Industries Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

LOTEPREDNOL ETABONATE

NDC Package Code : 65089-0037

Start Marketing Date : 1998-03-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Company Banner

06

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

LOTEPREDNOL ETABONATE

NDC Package Code : 63190-0220

Start Marketing Date : 1998-03-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

LOTEPREDNOL ETABONATE

NDC Package Code : 63190-0780

Start Marketing Date : 2012-09-28

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

LOTEPREDNOL ETABONATE

NDC Package Code : 55718-155

Start Marketing Date : 2012-10-12

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

09

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

LOTEPREDNOL ETABONATE

NDC Package Code : 55718-153

Start Marketing Date : 2011-04-15

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

10

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

LOTEPREDNOL ETABONATE

NDC Package Code : 55718-152

Start Marketing Date : 1998-03-09

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZach System is committed to providing Highly Customized Solutions for all your Development Programs.

Flag France
Digital Content Digital Content

Loteprednol Etabonate

About the Company : Zach System, a subsidiary of Zambon Company, provides Active Pharmaceutical Ingredients (APIs), intermediates, and custom synthesis services aligned with customer timelines and bud...

Zach System, a subsidiary of Zambon Company, provides Active Pharmaceutical Ingredients (APIs), intermediates, and custom synthesis services aligned with customer timelines and budgets. The company serves the generic drugs market, producing APIs for Zambon Pharma and offering process development expertise. Its cGMP-compliant facility in Avrillè, France, is FDA approved and equipped with reactors from 50 to 10,000 litres, advanced technologies, and integrated R&D and QC laboratories. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Zach System VB Company banner

02

Axplora

Germany
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora is your partner of choice for complex APIs.

Flag Germany
Digital Content Digital Content

Loteprednol Etabonate

About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...

Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.
Axplora CB

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Loteprednol Etabonate

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

Flag India
Digital Content Digital Content

Loteprednol Etabonate

About the Company : Gonane Pharma is a contract pharmaceutical company based in Gujarat, India, specializing in the manufacturing and marketing of corticosteroids, hormones, antivirals, and oncology p...

Gonane Pharma is a contract pharmaceutical company based in Gujarat, India, specializing in the manufacturing and marketing of corticosteroids, hormones, antivirals, and oncology products. The company is supported by a dedicated team and promoters with over 25 years of experience in manufacturing, product promotion, and regulatory audits across markets including the EU, Mexico, China, Korea, and Russia. Gonane Pharma is also engaged with Japanese customers and continues to expand into new markets. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Gonane Pharma

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Flag India
Digital Content Digital Content

Loteprednol Etabonate

About the Company : Aarti Pharmalabs is generic APIs & Intermediates manufacturing company & small molecule drug substance CDMO and the largest Indian manufacturer of Xanthine Derivatives (Caffeine, e...

Aarti Pharmalabs is generic APIs & Intermediates manufacturing company & small molecule drug substance CDMO and the largest Indian manufacturer of Xanthine Derivatives (Caffeine, etc.). It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 3 R&D centers and 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Aarti Industries Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Flag India
Digital Content Digital Content

Loteprednol Etabonate

About the Company : Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian manufacturer of APIs and intermediates. The company is approved by the FDA of India and holds cGMP certification for it...

Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian manufacturer of APIs and intermediates. The company is approved by the FDA of India and holds cGMP certification for its products, while also complying with WHO GMP standards. Bhavna focuses on muscle relaxants and ophthalmic products and provides custom manufacturing services. Its cGMP-compliant facility near Mumbai has a production capacity exceeding 500 tonnes per year, with exports across Southeast Asia, the Middle East, and Europe. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Bhavna Labs

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Loteprednol Etabonate

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

08

CHEMO

Spain
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

CHEMO

Spain
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Loteprednol Etabonate

About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).
blank

09

NEWCHEM SPA

Italy
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

NEWCHEM SPA

Italy
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Loteprednol Etabonate

About the Company : NEWCHEM is an independent Italian manufacturer of Active Pharmaceutical Ingredients (APIs) - Steroids, Progestogens, Prostafglandins. NEWCHEM is active on the worldwide Pharmaceut...

NEWCHEM is an independent Italian manufacturer of Active Pharmaceutical Ingredients (APIs) - Steroids, Progestogens, Prostafglandins. NEWCHEM is active on the worldwide Pharmaceutical Manufacturing market. Quality and reliability are guaranteed by the proven experience of EFFECHEM. NEWCHEM recruits only highly specialized personnel to work in compliance with the strictest regulations.The company is constantly updating its procedures to meet the most advanced quality and safety requirements.
blank

10

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Loteprednol Etabonate

About the Company : Parth Antibiotics Pvt. Ltd. Established in decade ago as a Indenting, Exporting & Trading house with Head Office in Mumbai for Pharmaceutical API, Intermediate, Excipient, Chemical...

Parth Antibiotics Pvt. Ltd. Established in decade ago as a Indenting, Exporting & Trading house with Head Office in Mumbai for Pharmaceutical API, Intermediate, Excipient, Chemicals . It has attained leadership with growth and meeting high marketing standards. With the Growth of the business, Parth Antibiotics Pvt .Ltd. have look forward & diversified to Flavours, Food & Nutraceuticals Products.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - OINTMENT;OPHTHALMIC - 0.5%

USFDA APPLICATION NUMBER - 200738

read-more

DOSAGE - GEL;OPHTHALMIC - 0.38%

USFDA APPLICATION NUMBER - 208219

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Disintegrants & Superdisintegrants

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Topical

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Emulsifying Agents

read-more
read-more

Taste Masking

read-more
read-more

Coating Systems & Additives

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 82034-46-6 / Loteprednol Etabonate API manufacturers, exporters & distributors?

Loteprednol Etabonate manufacturers, exporters & distributors 1

12

PharmaCompass offers a list of Loteprednol Etabonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Loteprednol Etabonate manufacturer or Loteprednol Etabonate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Loteprednol Etabonate manufacturer or Loteprednol Etabonate supplier.

API | Excipient name

Loteprednol Etabonate

Synonyms

82034-46-6, Lotemax, Alrex, Hgp-1, Inveltys, Cddd-5604

Cas Number

82034-46-6

Unique Ingredient Identifier (UNII)

YEH1EZ96K6

About Loteprednol Etabonate

An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.

Lotemax (TN) Manufacturers

A Lotemax (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lotemax (TN), including repackagers and relabelers. The FDA regulates Lotemax (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lotemax (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Lotemax (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Lotemax (TN) Suppliers

A Lotemax (TN) supplier is an individual or a company that provides Lotemax (TN) active pharmaceutical ingredient (API) or Lotemax (TN) finished formulations upon request. The Lotemax (TN) suppliers may include Lotemax (TN) API manufacturers, exporters, distributors and traders.

click here to find a list of Lotemax (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Lotemax (TN) USDMF

A Lotemax (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Lotemax (TN) active pharmaceutical ingredient (API) in detail. Different forms of Lotemax (TN) DMFs exist exist since differing nations have different regulations, such as Lotemax (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Lotemax (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Lotemax (TN) USDMF includes data on Lotemax (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lotemax (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Lotemax (TN) suppliers with USDMF on PharmaCompass.

Lotemax (TN) KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Lotemax (TN) Drug Master File in Korea (Lotemax (TN) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lotemax (TN). The MFDS reviews the Lotemax (TN) KDMF as part of the drug registration process and uses the information provided in the Lotemax (TN) KDMF to evaluate the safety and efficacy of the drug.

After submitting a Lotemax (TN) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lotemax (TN) API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Lotemax (TN) suppliers with KDMF on PharmaCompass.

Lotemax (TN) WC

A Lotemax (TN) written confirmation (Lotemax (TN) WC) is an official document issued by a regulatory agency to a Lotemax (TN) manufacturer, verifying that the manufacturing facility of a Lotemax (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lotemax (TN) APIs or Lotemax (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Lotemax (TN) WC (written confirmation) as part of the regulatory process.

click here to find a list of Lotemax (TN) suppliers with Written Confirmation (WC) on PharmaCompass.

Lotemax (TN) NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lotemax (TN) as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Lotemax (TN) API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Lotemax (TN) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Lotemax (TN) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lotemax (TN) NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Lotemax (TN) suppliers with NDC on PharmaCompass.

Lotemax (TN) GMP

Lotemax (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Lotemax (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lotemax (TN) GMP manufacturer or Lotemax (TN) GMP API supplier for your needs.

Lotemax (TN) CoA

A Lotemax (TN) CoA (Certificate of Analysis) is a formal document that attests to Lotemax (TN)'s compliance with Lotemax (TN) specifications and serves as a tool for batch-level quality control.

Lotemax (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Lotemax (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Lotemax (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Lotemax (TN) EP), Lotemax (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lotemax (TN) USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty